Members |
targetComponentId |
30 minute plasma glucose level |
30 minute plasma glucose measurement (procedure) |
30 minute plasma prolactin level |
30 minute plasma prolactin measurement |
30 minute plasma prolactin level |
30 minute plasma prolactin measurement |
30 minute serum FSH level |
30 minute serum FSH measurement |
30 minute serum FSH level |
30 minute serum FSH measurement |
30 minute serum GH level |
30 minute serum GH measurement |
30 minute serum GH level |
30 minute serum GH measurement |
30 minute serum LH level |
30 minute serum LH measurement |
30 minute serum LH level |
30 minute serum LH measurement |
30 minute serum TSH level |
Measurement of serum thyroid stimulating hormone concentration 30 minutes after challenge (procedure) |
30 minute serum TSH level |
Measurement of serum thyroid stimulating hormone concentration 30 minutes after challenge (procedure) |
30 minute serum cortisol level |
30 minute serum cortisol measurement |
30 minute serum cortisol level |
30 minute serum cortisol measurement |
30 minute serum glucose level |
30 minute serum glucose measurement |
30 minute serum glucose level |
30 minute serum glucose measurement |
30 minute serum prolactin level |
30 minute serum prolactin measurement |
30 minute serum prolactin level |
30 minute serum prolactin measurement |
360 degree sweep of cervix not performed |
360 degree sweep of cervix not performed |
360 degree sweep of cervix not performed |
360 degree sweep of cervix not performed |
360 degree sweep of cervix performed |
360 degree sweep of cervix performed |
360 degree sweep of cervix performed |
360 degree sweep of cervix performed |
3rd HiB and DTP vaccine given |
Third Haemophilus influenzae type b and diphtheria, tetanus and pertussis vaccine given (situation) |
3rd Japanese encephalitis vaccination |
Administration of third dose of Japanese encephalitis vaccine |
3rd Japanese encephalitis vaccination |
Administration of third dose of Japanese encephalitis vaccine |
4,7,10,13,16,19-Docosahexaenoic acid |
Docosahexaenoic acid |
4-4'Methylene bis (2-chloroaniline) |
4,4'-methylene-bis-(2-chloroaniline) (substance) |
4-Chloro-3,5- xylenol |
Product containing chloroxylenol (medicinal product) |
4-Chloro-3,5- xylenol |
Chloroxylenol (substance) |
4-Hydroxybenzoate 3-monooxygenase |
4-hydroxybenzoate 3-monooxygenase (NAD(P)H) |
4-Methylaminophenol sulfate |
p-methylaminophenol sulfate (substance) |
4-hydroxycatechol 1,2-dioxygenase |
Hydroxyquinol 1,2-dioxygenase |
4-tert-Butylphenol formaldehyde resin |
4-tert-butylphenol formaldehyde resin (substance) |
4-tert-Butylphenol formaldehyde resin |
4-tert-butylphenol formaldehyde resin (substance) |
4-tertiary Butylcatechol |
4-tertiary butylcatechol (substance) |
4.5 year exam. normal |
4.5 year examination normal (finding) |
4.5 year exam. not wanted |
4.5 year examination not wanted |
4.5 year examination abnormal - for observation |
4.5 year examination abnormal - for observation |
4.5 year examination abnormal - on treatment |
4.5 year examination abnormal - on treatment |
4.5 year examination abnormal - referred |
4.5 year examination abnormal - referred |
5-Aminolevulinate synthase |
5-aminolevulinate synthase |
5-Chloro-7-iodo-quinolinol |
Product containing clioquinol (medicinal product) |
5-Chloro-7-iodo-quinolinol |
Clioquinol (substance) |
5-Hydroxy-indoleacetic acid |
5-hydroxyindole acetic acid (substance) |
5-Hydroxyindoleacetic acid |
5-hydroxyindole acetic acid (substance) |
5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent |
5-HT3-receptor antagonist overdose |
5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent |
5-HT3-receptor antagonist poisoning |
5-Oxoproline |
Pyroglutamic acid |
5-aminosalicylic acid |
Product containing mesalazine (medicinal product) |
5-aminosalicylic acid overdose of undetermined intent |
5-aminosalicylic acid overdose |
5-aminosalicylic acid poisoning of undetermined intent |
5-aminosalicylic acid poisoning |
6 week examination abnormal - for observation |
6 week examination abnormal - for observation |
6 week examination abnormal - on treatment |
6 week examination abnormal - on treatment |
6 week examination abnormal - referred |
6 week examination abnormal - referred |
60 minute blood glucose level |
60 minute blood glucose measurement (procedure) |
60 minute blood glucose level |
60 minute blood glucose measurement (procedure) |
60 minute plasma FSH level |
60 minute plasma FSH measurement |
60 minute plasma FSH level |
60 minute plasma FSH measurement |
60 minute plasma GH level |
60 minute plasma GH measurement |
60 minute plasma GH level |
60 minute plasma GH measurement |
60 minute plasma LH level |
60 minute plasma LH measurement |
60 minute plasma LH level |
60 minute plasma LH measurement |
60 minute plasma TSH level |
60 minute plasma TSH measurement |
60 minute plasma TSH level |
60 minute plasma TSH measurement |
60 minute plasma cortisol level |
60 minute plasma cortisol measurement |
60 minute plasma cortisol level |
60 minute plasma cortisol measurement |
60 minute plasma glucose level |
60 minute plasma glucose measurement |
60 minute plasma glucose level |
60 minute plasma glucose measurement |
60 minute plasma prolactin level |
60 minute plasma prolactin measurement |
60 minute plasma prolactin level |
60 minute plasma prolactin measurement |
60 minute plasma xylose level |
60 minute plasma xylose level (procedure) |
60 minute serum FSH level |
60 minute serum FSH measurement |
60 minute serum FSH level |
60 minute serum FSH measurement |
60 minute serum GH level |
60 minute serum GH measurement |
60 minute serum GH level |
60 minute serum GH measurement |
60 minute serum LH level |
60 minute serum LH measurement |
60 minute serum LH level |
60 minute serum LH measurement |
60 minute serum TSH level |
Measurement of serum thyroid stimulating hormone concentration 60 minutes after challenge (procedure) |
60 minute serum TSH level |
Measurement of serum thyroid stimulating hormone concentration 60 minutes after challenge (procedure) |
60 minute serum cortisol level |
60 minute serum cortisol measurement (procedure) |
60 minute serum cortisol level |
60 minute serum cortisol measurement (procedure) |
60 minute serum glucose level |
60 minute serum glucose measurement |
60 minute serum glucose level |
60 minute serum glucose measurement |
60 minute serum prolactin level |
60 minute serum prolactin measurement |
60 minute serum prolactin level |
60 minute serum prolactin measurement |
60-80% of predicted peak flow rate |
60 to 80 percent of predicted peak expiratory flow rate |
60-80% of predicted peak flow rate |
60 to 80 percent of predicted peak expiratory flow rate |
8 week examination abnormal - for observation |
8 week examination abnormal - for observation |
8 week examination abnormal - on treatment |
8 week examination abnormal - on treatment |
8 week examination abnormal - referred |
8 week examination abnormal - referred |
8-9 month exam normal |
8-9 month exam normal |
8-9 month exam not wanted |
8-9 month exam not wanted |
8-9 month examination abnormal: for observation |
8-9 month examination abnormal - for observation (finding) |
8-9 month examination abnormal: on treatment |
8-9 month examination abnormal - on treatment (finding) |
8-9 month examination abnormal: referred |
8-9 month examination abnormal - referred (finding) |
9-hydroxyrisperidone |
Paliperidone (substance) |
90 minute blood glucose level |
90 minute blood glucose measurement |
90 minute blood glucose level |
90 minute blood glucose measurement |
90 minute plasma FSH level |
90 minute plasma FSH measurement |
90 minute plasma FSH level |
90 minute plasma FSH measurement |
90 minute plasma GH level |
90 minute plasma GH measurement |
90 minute plasma GH level |
90 minute plasma GH measurement |